Pentavalent Meningococcal Vaccine Among Latest EU Filings

 
• By Neena Brizmohun

Marketing applications for MenABCWY, zolbetuximab, crovalimab, macitentan/tadalafil, Coacillium, mRNA-1345, dasiglucagon and ustekinumab have been submitted to the European Medicines Agency for review.

EU marketing applications for new medicines have started the review process • Source: Shutterstock

More from Product Reviews

More from Pink Sheet